BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34450587)

  • 21. Molecular targeting of malignant glioma cells with an EphA2-specific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells.
    Sun XL; Xu ZM; Ke YQ; Hu CC; Wang SY; Ling GQ; Yan ZJ; Liu YJ; Song ZH; Jiang XD; Xu RX
    Cancer Lett; 2011 Dec; 312(2):168-77. PubMed ID: 21924825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D3-inducible mesenchymal stem cell-based delivery of conditionally replicating adenoviruses effectively targets renal cell carcinoma and inhibits tumor growth.
    Hsiao WC; Sung SY; Liao CH; Wu HC; Hsieh CL
    Mol Pharm; 2012 May; 9(5):1396-408. PubMed ID: 22480282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
    Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
    J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts.
    Wildburger NC; Zhou S; Zacharias LG; Kroes RA; Moskal JR; Schmidt M; Mirzaei P; Gumin J; Lang FF; Mechref Y; Nilsson CL
    J Proteome Res; 2015 Sep; 14(9):3932-9. PubMed ID: 26185906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow-derived from the human femoral shaft as a new source of mesenchymal stem/stromal cells: an alternative cell material for banking and clinical transplantation.
    Drela K; Stanaszek L; Snioch K; Kuczynska Z; Wrobel M; Sarzynska S; Legosz P; Maldyk P; Lukomska B
    Stem Cell Res Ther; 2020 Jun; 11(1):262. PubMed ID: 32605638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System.
    Jones M; Varella-Garcia M; Skokan M; Bryce S; Schowinsky J; Peters R; Vang B; Brecheisen M; Startz T; Frank N; Nankervis B
    Cytotherapy; 2013 Nov; 15(11):1323-39. PubMed ID: 23992670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
    Shahar T; Rozovski U; Hess KR; Hossain A; Gumin J; Gao F; Fuller GN; Goodman L; Sulman EP; Lang FF
    Neuro Oncol; 2017 May; 19(5):660-668. PubMed ID: 28453745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.
    Balvers RK; Belcaid Z; van den Hengel SK; Kloezeman J; de Vrij J; Wakimoto H; Hoeben RC; Debets R; Leenstra S; Dirven C; Lamfers ML
    Viruses; 2014 Aug; 6(8):3080-96. PubMed ID: 25118638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal cells from limbal stroma of human eye.
    Polisetty N; Fatima A; Madhira SL; Sangwan VS; Vemuganti GK
    Mol Vis; 2008 Mar; 14():431-42. PubMed ID: 18334960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma.
    Egea V; von Baumgarten L; Schichor C; Berninger B; Popp T; Neth P; Goldbrunner R; Kienast Y; Winkler F; Jochum M; Ries C
    Cell Death Differ; 2011 May; 18(5):853-63. PubMed ID: 21127499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.
    Ahmed AU; Thaci B; Alexiades NG; Han Y; Qian S; Liu F; Balyasnikova IV; Ulasov IY; Aboody KS; Lesniak MS
    Mol Ther; 2011 Sep; 19(9):1714-26. PubMed ID: 21629227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell RNA-seq of out-of-thaw mesenchymal stromal cells shows tissue-of-origin differences and inter-donor cell-cycle variations.
    Medrano-Trochez C; Chatterjee P; Pradhan P; Stevens HY; Ogle ME; Botchwey EA; Kurtzberg J; Yeago C; Gibson G; Roy K
    Stem Cell Res Ther; 2021 Nov; 12(1):565. PubMed ID: 34736534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.
    Geletneky K; Huesing J; Rommelaere J; Schlehofer JR; Leuchs B; Dahm M; Krebs O; von Knebel Doeberitz M; Huber B; Hajda J
    BMC Cancer; 2012 Mar; 12():99. PubMed ID: 22436661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.
    Li O; Tormin A; Sundberg B; Hyllner J; Le Blanc K; Scheding S
    PLoS One; 2013; 8(1):e55319. PubMed ID: 23383153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential.
    Siegel G; Krause P; Wöhrle S; Nowak P; Ayturan M; Kluba T; Brehm BR; Neumeister B; Köhler D; Rosenberger P; Just L; Northoff H; Schäfer R
    Stem Cells Dev; 2012 Sep; 21(13):2457-70. PubMed ID: 22309203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity.
    Castleton A; Dey A; Beaton B; Patel B; Aucher A; Davis DM; Fielding AK
    Blood; 2014 Feb; 123(9):1327-35. PubMed ID: 24345754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.
    Hossain A; Gumin J; Gao F; Figueroa J; Shinojima N; Takezaki T; Priebe W; Villarreal D; Kang SG; Joyce C; Sulman E; Wang Q; Marini FC; Andreeff M; Colman H; Lang FF
    Stem Cells; 2015 Aug; 33(8):2400-15. PubMed ID: 25966666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.